SuperUser Account / Thursday, June 30, 2022 / Categories: RT News Hedge funds scoop up biotech stocks after ‘catastrophic’ declines Some managers expect cheaper valuations will fuel M&A activity Previous Article Treasury market reforms draw flak from funds and high-speed traders Next Article New Zealand’s dreamland: property sales rise in Queenstown Print 28